Your browser doesn't support javascript.
loading
[Preliminary clinical analysis of direct renin inhibitor aliskiren in the treatment of severe coronavirus disease 2019 patients with hypertension].
Guo, Y; Zeng, J; Li, Q; Li, P; Luo, F M; Zhang, W Z; Lu, Y X; Wang, Q; Zhang, W; Zeng, Z P; Liu, L S.
Afiliação
  • Guo Y; Departments of Endocrinology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China; Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China.
  • Zeng J; Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China; Department of Aviation Disease, Naval Medical Center of PLA,The Second Military Medical University, Shanghai 200052,China.
  • Li Q; Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China; Department of Neurosurgery, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.
  • Li P; Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China; Departments of Cardiology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.
  • Luo FM; Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041,China.
  • Zhang WZ; Shanghai Institute of Hypertension, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
  • Lu YX; Department of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022,China.
  • Wang Q; Division of Nephrology and Hypertension, University Hospital Lausanne (CHUV) , Lausanne CH-1011, Switzerland.
  • Zhang W; Deparment of Infectious Disease, Guanggu District, Hubei Province Maternal and Child Health Care Hospital, Wuhan 430200, China; Department of Respiratory and Critical Care Medicine, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.
  • Zeng ZP; Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Liu LS; Departments of Cardiology, Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100037, China.
Zhonghua Nei Ke Za Zhi ; 59(8): 610-617, 2020 Aug 01.
Article em Zh | MEDLINE | ID: mdl-32340096

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Renina / COVID-19 / Hipertensão / Anti-Hipertensivos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Renina / COVID-19 / Hipertensão / Anti-Hipertensivos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China